BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21495260)

  • 1. Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers.
    Tomita M; Doi N; Hayashi M
    Eur J Drug Metab Pharmacokinet; 2010 Sep; 35(1-2):1-7. PubMed ID: 21495260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers.
    Doi N; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2011; 26(2):162-70. PubMed ID: 21206134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in bioavailability of poorly absorbed drug by acylcarnitine.
    Tomita M; Doi N; Kimura A; Hayashi M
    J Pharm Sci; 2012 Sep; 101(9):3511-7. PubMed ID: 22678774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
    Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
    Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
    Wu SJ; Robinson JR
    Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of mitochondrial volume changes by homologous O-acyl carnitines].
    Seim H; Dargel R
    Acta Biol Med Ger; 1978; 37(1):73-82. PubMed ID: 706930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
    Dunkoksung W; Vardhanabhuti N; Jianmongkol S
    J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum.
    Yamada KA; Kanter EM; Newatia A
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):14-21. PubMed ID: 10892655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.
    Bentz J; Ellens H
    Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soybean Oil-Based Lipid Emulsion Increases Intestinal Permeability of Lipopolysaccharide in Caco-2 Cells by Downregulation of P-Glycoprotein via ERK-FOXO 3a Pathway.
    Yan JK; Zhu J; Gu BL; Yan WH; Xiao YT; Zhou KJ; Wen J; Wang Y; Cai W
    Cell Physiol Biochem; 2016; 39(4):1581-94. PubMed ID: 27627102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits.
    Kajikawa T; Mishima HK; Murakami T; Takano M
    Curr Eye Res; 1999 Mar; 18(3):240-6. PubMed ID: 10342379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.
    Zastre J; Jackson J; Burt H
    Pharm Res; 2004 Aug; 21(8):1489-97. PubMed ID: 15359586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
    Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
    Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
    Su Y; Zhang X; Sinko PJ
    Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of efflux transporters involved in distribution and disposition of apixaban.
    Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
    Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.